One hundred forty-eight patients with advanced CRC previously treated with fluoropyrimidine or irinotecan received bevacizumab ( @ mg/kg , intravenous ) , low-dose linifanib ( @ mg ) , or high-dose linifanib ( @ mg ) , with mFOLFOX@ .